 Clarivate Analytics Plc NYSE:CCC a global leader in providing trusted insights and analytics to accelerate the pace of innovation, today announced that Cortellis Clinical Trials IntelligenceTM has been enhanced with new site selection analytics. Cortellis Clinical Trials Intelligence is a powerful and user-friendly resource to plan clinical trials, helping to accelerate clinical trial development decisions, select trial sites, inform portfolio strategy and provide key competitive intelligence. 